Back to results
US 2015/0148332 A1Published application
Triazolo compounds as pde10 inhibitors
AssigneeHoffmann-La Roche Inc.
InventorsAlexander Flohr, Katrin Groebke Zbinden, Bernd Kuhn, Christian Lerner, Markus Rudolph, Herve Schaffhauser
Life of this patent
Estimating the term…
Abstract
The present invention provides compounds of formula (Ia) and (Ib) wherein R1, R2, R3 and R4 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit PDE10A and can be used as medicaments.
Claims13
A compound of formula (Ia) or (Ib)
- wherein
- B is C1-C4-alkylene, C2-C4-alkenylene, C2-C4-alkynylene, C3-C5-cycloalkyl,
- R1 and R2, are independently selected from hydrogen, C1-C7-alkyl optionally substituted by C3-C5-cycloalkyl;
- C1-C7-hydroxyalkyl, C1-C7-alkoxyalkyl, C1-C7-haloalkyl, C3-C5-cycloalkyl, R1 and R2 together with the nitrogen atom to which they are attached, form a azaspirocycloalkyl, a bicyclic ring or heterocycloalkyl which can be substituted by 1 to 3 substituents independently selected from the group consisting of halogen, C1-C7-alkyl, C1-C7-alkoxyalkyl;
- C1-C7-hydroxyalkyl, C1-C7-alkoxy, C1-C7 haloalkyl, hydroxyl, —NR9R10 and oxo;
- R3 is selected from hydrogen, C3-C5-cycloalkyl, C1-C7-alkoxyalkyl, C1-C7-haloalkyl, heterocycloalkyl, —(CH2)0,1,2-aryl optionally substituted by C1-C7-alkoxy and C1-C7-alkyl optionally substituted by C3-C5-cycloalkyl;
- R4 is selected from heteroaryl optionally substituted by 1 to 3 substituents selected from halogen, C1-C7-alkyl, C1-C7-hydroxyalkyl, C1-C7-haloalkoxy, C1-C7-haloalkyl, C3-C5-cycloalkyl, cyano, amino, nitro, —O—R6—C(O)—R7, —SO2R8, C1-C2-alkoxy optionally substituted by C1-C2-alkoxy, heterocycloalkyl,
- R6 and R8 are selected from C1-C7-alkyl,
- R7 is selected from heterocycloalkyl,
- R9 and R10 are independently selected from hydrogen, C1-C7-alkyl, C(O)—O— C1-C7-alkyl.
7 more elements
9-11. (canceled)
(canceled)
Dependencies are inferred from the claim text.